je.st
news
Teva Pharmaceutical Industries Ltd (TEVA) Earns Buy Rating from Analysts at Mizuho
2015-12-14 04:17:40| Biotech - Topix.net
The brokerage set a "buy" rating and a $79.00 price target on the stock. Mizuho's price objective would suggest a potential upside of 22.50% from the company's current price.
Tags: buy
rating
industries
pharmaceutical
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||